Identification of coffee components that stimulate dopamine release from pheochromocytoma cells (PC-12)

Food and Chemical Toxicology

Volumn 50, Issue 2, 2012, Pages 390-398

  Walker, J ^a,b   Rohm, B ^a   Lang, R ^c   Pariza, M W ^b   Hofmann, T ^c   Somoza, V ^a,b  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Ca 2+ mobilization; Coffee; Coffee constituents; Dopamine release; PC 12 cells

Indexed keywords

5 HYDROXYTRYPTAMIDE; CAFFEINE; CATECHOL; CHLOROGENIC ACID; N METHYLPYRIDINIUM; PYRIDINIUM DERIVATIVE; PYROGALLOL; TRIGONELLINE; TRYPTAMIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BLOOD LEVEL; CALCIUM MOBILIZATION; CALCIUM SIGNALING; CELL STIMULATION; COFFEE; CONTROLLED STUDY; DOPAMINE RELEASE; FOOD COMPOSITION; NONHUMAN; PHEOCHROMOCYTOMA CELL;

ADRENAL GLAND NEOPLASMS; ANIMALS; CALCIUM; COFFEE; DOPAMINE; MOLECULAR STRUCTURE; PC12 CELLS; PHEOCHROMOCYTOMA; RATS; SEEDS;

COFFEA ARABICA; COFFEA CANEPHORA;

EID: 84855267433     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2011.09.041     Document Type: Article

References (53)

1. Avidor T., Clementi E., Schwartz L., Atlas D. Caffeine-induced transmitter release is mediated via ryanodine-sensitive channel. Neurosci. Lett. 1994, 165:133-136.
2. Balant L., Burki B., Wermeille M., Golden G. Comparison of some pharmacokinetic parameters of (+)-cyanidanol-3 obtained with specific and nonspecific analytical methods. Arzneimittel-Forschung 1979, 29-2:1758-1762.
3. Banks W.A. Characteristics of compounds that cross the blood-brain barrier. BMC Neurol. 2009, 9(Suppl. 1):S3.
4. Battig K., Welzl H. Psychopharmacological profile of caffeine. Monographs of the Mario Negri Institute for Pharmacological Research Milan; Caffeine, coffee, and health 1993, 213-253. RavenPress, New York. S. Garattini (Ed.).
5. Bekedam E.K., Roos E., Schols H.A., Van Boekel M.A., Smit G. Low molecular weight melanoidins in coffee brew. J. Agric. Food Chem. 2008, 56:4060-4067.
6. Binda F., Dipace C., Bowton E., Robertson S.D., Lute B.J., Fog J.U., Zhang M., Sen N., Colbran R.J., Gnegy M.E., Gether U., Javitch J.A., Erreger K., Galli A. Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux. Mol. Pharmacol. 2008, 74:1101-1108.
7. Blanchard J., Sawers S.J. The absolute bioavailability of caffeine in man. Eur. J. Clin. Pharmacol. 1983, 24:93-98.
8. Boettler U., Sommerfeld K., Volz N., Pahlke G., Teller N., Somoza V., Lang R., Hofmann T., Marko D. Coffee constituents as modulators of Nrf2 nuclear translocation and ARE (EpRE)-dependent gene expression. J. Nutr. Biochem. 2011, 22:426-440.
9. Bruhl L., Matthaus B., Fehling E., Wiege B., Lehmann B., Luftmann H., Bergander K., Quiroga K., Scheipers A., Frank O., Hofmann T. Identification of bitter off-taste compounds in the stored cold pressed linseed oil. J. Agric. Food Chem. 2007, 55:7864-7868.
10. Chu Y.F., Brown P.H., Lyle B.J., Chen Y., Black R.M., Williams C.E., Lin Y.C., Hsu C.W., Cheng I.H. Roasted coffees high in lipophilic antioxidants and chlorogenic acid lactones are more neuroprotective than green coffees. J. Agric. Food Chem. 2009, 57:9801-9808.
11. Cornford E.M., Young D., Paxton J.W. Comparison of the blood-brain barrier and liver penetration of acridine antitumor drugs. Cancer Chemother. Pharmacol. 1992, 29:439-444.
12. Dayan P. Dopamine, reinforcement learning, and addiction. Pharmacopsychiatry 2009, 42:S56-S65.
13. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA 1988, 85:5274-5278.
14. Eshleman A.J., Henningsen R.A., Neve K.A., Janowsky A. Release of dopamine via the human transporter. Mol. Pharmacol. 1994, 45:312-316.
15. Farnsworth S.J., Volz T.J., Hanson G.R., Fleckenstein A.E. Cocaine alters vesicular dopamine sequestration and potassium-stimulated dopamine release: the role of D2 receptor activation. J. Pharmacol. Exp. Ther. 2009, 328:807-812.
16. Fernstrom J.D. Can nutrient supplements modify brain function?. Am. J. Clin. Nutr. 2000, 71:1669-1673.
17. Ferre S. Role of the central ascending neurotransmitter systems in the psychostimulant effects of caffeine. J. Alzheimers Dis. 2010, 20(Suppl. 1):S35-S49.
18. Frank O., Blumberg S., Kunert C., Zehentbauer G., Hofmann T. Structure determination and sensory analysis of bitter-tasting 4-vinylcatechol oligomers and their identification in roasted coffee by means of LC-MS/MS. J. Agric. Food Chem. 2007, 55:1945-1954.
19. Geel L., Kinnear M., de Kock H.L. Relating consumer preferences to sensory attributes of instant coffee. Food Qual. Prefer. 2005, 16:237-244.
20. Goldberg D.A., Yan J., Soleas G.J. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin. Biochem. 2003, 36:79-87.
21. Greene L.A., Tischler A.S. Establishment of noradrenogenic clonal line of rat adrenal pheocytochroma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA 1976, 73:2424-2428.
22. Holt R.R., Lazarus S.A., Sullards M.C., Zhu Q.Y., Schramm D.D., Hammerstone J.F., Fraga C.G., Schmitz H.H., Keen C.L. Procyanidin dimer B2 [epicatechin-(4 beta-8)-epicatechin] in human plasma after the consumption of a flavanol-rich cocoa. Am. J. Clin. Nutr. 2002, 76:798-804.
23. A receptors expressed in Xenopus oocytes. J. Agric. Food Chem. 2003, 51:7568-7575.
24. 2 receptors in the nucleus accumbens in mediating reward. J. Neurosci. 1997, 17:8580-8587.
25. Jaffe L.F. Free calcium signals. Science 1998, 279:1833.
26. Johnson L.A., Guptaroy B., Lund D., Shamban S., Gnegy M.E. Regulation of amphetamine-stimulated dopamine efflux by protein kinase C beta. J. Biol. Chem. 2005, 280:10914-10919.
27. Kaasinen V., Aalto S., Nagren K., Rinne J.O. Expectation of caffeine induces dopaminergic responses in humans. Eur. J. Neurosci. 2004, 19:2352-2356.
28. Koizumi S., Rosa P., Willars G.B., Challiss R.A., Taverna E., Francolini M., Bootman M.D., Lipp P., Inoue K., Roder J., Jeromin A. Mechanisms underlying the neuronal calcium sensor-1-evoked enhancement of exocytosis in PC12 cells. J. Biol. Chem. 2002, 277:30315-30324.
29. Koshimura K., Tanaka J., Murakami Y., Kato Y. Effect of high concentration of glucose on dopamine release from pheochromocytoma-12 cells. Metabolism 2003, 52:922-926.
30. Lafay S., Morand C., Manach C., Besson C., Scalbert A. Absorption and metabolism of caffeic acid and chlorogenic acid in the small intestine of rats. Br. J. Nutr. 2006, 96:39-46.
31. Lang R., Bardelmeier I., Weiss C., Rubach M., Somoza V., Hofmann T. Quantitation of (beta)N-Alkanoyl-5-hydroxytryptamides in coffee by means of LC-MS/MS-SIDA and assessment of their gastric acid secretion potential using the HGT-1 cell assay. J. Agric. Food Chem. 2010, 58:1593-1602.
32. Lang R., Wahl A., Skurk T., Yagar E.F., Schmiech L., Eggers R., Hauner H., Hofmann T. Development of a hydrophilic liquid interaction chromatography-high-performance liquid chromatography-tandem mass spectrometry based stable isotope dilution analysis and pharmacokinetic studies on bioactive pyridines in human plasma and urine after coffee consumption. Anal. Chem. 2010, 82:1486-1497.
33. Lautala P., Ulmanen I., Taskinen J. Molecular mechanisms controlling the rate and specificity of catechol O-methylation by human soluble catechol O-methyltransferase. Mol. Pharmacol. 2001, 59:393-402.
34. Lin L.C., Wang M.N., Tseng T.Y., Sung J.S., Tsai T.H. Pharmacokinetics of (-)-epigallocatechin-3-gallate in conscious and freely moving rats and its brain regional distribution. J. Agric. Food Chem. 2007, 55:1517-1524.
35. McCall A.L., Millington W.R., Wurtman R.J. Blood-brain barrier transport of caffeine: dose-related restriction of adenine transport. Life Sci. 1982, 31:2709-2715.
36. Michaelis M.L., Michaelis E.K., Myers S.L. Adenosine modulation of synaptosomal dopamine release. Life Sci. 1979, 24:2083-2092.
37. Minchin M.C., Pearson G. The effect of the convulsant agent, catechol, on neurotransmitter uptake and release in rat brain slices. Br. J. Pharmacol. 1981, 74:715-721.
38. Monteiro M., Farah A., Perrone D., Trugo L.C., Donangelo C. Chlorogenic acid compounds from coffee are differentially absorbed and metabolized in humans. J. Nutr. 2007, 137:2196-2201.
39. Morgan M.E.V.R.E. Methylxanthine effects on caudate dopamine release as measured by in vivo electrochemistry. Life Sci. 1998, 45:2025-2039.
40. Nehlig A., Daval J.L., Debry G. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res. Rev. 1992, 17:139-170.
41. Newton R., Broughton L.J., Lind M.J., Morrison P.J., Rogers H.J., Bradbrook I.D. Plasma and salivary pharmacokinetics of caffeine in man. Eur. J. Clin. Pharmacol. 1981, 21:45-52.
42. Pontieri F.E., Tanda G., Di Chiara G. Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of rat nucleus accumbens. Proc. Natl. Acad. Sci. USA 1995, 92:12304-12308.
43. Pop E., Shek E., Murakami T., Bodor N.S. Improved anticonvulsant activity of phenytoin by a redox brain delivery system I: Synthesis and some properties of the dihydropyridine derivatives. J. Pharm. Sci. 1989, 78:609-616.
44. Rubach M., Lang R., Hofmann T., Somoza V. Time-dependent component-specific regulation of gastric acid secretion-related proteins by roasted coffee constituents. Ann. NY. Acad. Sci. 2008, 1126:310-314.
45. Rubach M., Lang R., Skupin C., Hofmann T., Somoza V. Activity-guided fractionation to characterize a coffee beverage that effectively down-regulates mechanisms of gastric acid secretion as compared to regular coffee. J. Agric. Food Chem. 2010, 58:4153-4161.
46. Shinohara H., Wang F., Hossain S.M. A convenient, high-throughput method for enzyme-luminescence detection of dopamine released from PC12 cells. Nat. Protoc. 2008, 3:1639-1644.
47. Solinas M., Ferre S., You Z.-B., Karcz-Kubicha M., Popoli P., Goldberg S.R. Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens. J. Neurosci. 2002, 22:6321-6324.
48. Somoza V., Lindenmeier M., Wenzel E., Frank O., Erbersdobler H.F., Hofmann T. Activity-guided identification of a chemopreventive compound in coffee beverage using in vitro and in vivo techniques. J. Agric. Food Chem. 2003, 51:6861-6869.
49. Stadler R.H., Varga N., Hau J., Vera F.A., Welti D.H. Alkylpyridiniums. 1. Formation in model systems via thermal degradation of trigonelline. J. Agric. Food Chem. 2002, 50:1192-1199.
50. Tohda C., Nakamura N., Komatsu K., Hattori M. Trigonelline-induced neurite outgrowth in human neuroblastoma SK-N-SH cells. Biol. Pharm. Bull. 1999, 22:679-682.
51. 2+-induced vesicular catecholamine release from rat PC12 cells. Brain Res. 2002, 957:25-36.
52. Wood P.L., Kim H.S., Boyar W.C., Hutchison A. Inhibition of nigro-stratial release of dopamine in the rat by adenosine receptor agonists: A1 receptor mediation. Neuropharmacology 1989, 28:21-25.
53. Zhu J., Filippich L.J., Ng J. Rumen involvement in sheep tannic acid metabolism. Vet. Hum. Toxicol. 1995, 37:436-440.